United Therapeutics (UTHR) Tops Q4 EPS Views
Get Alerts UTHR Hot Sheet
Price: $236.93 +0.69%
EPS Growth %: +19.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: +19.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Chemung Financial (CHMG) Tops Q1 EPS by 44c
- P.A.M. Transportation Services (PTSI) Misses Q1 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!